Purchase Order 75N95026P00013
- Not listed
- This is a $2,036,522.37 definitive cost-reimbursement contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The Johns Hopkins University to provide clinical services and resources for NIDA's Intramural Research Program (IRP) in Baltimore, Maryland. The contract has a base period of six months and nine six-month option periods, running through June 2025. The contract was awarded on July 1, 2020 and does not have a set-aside...
- This federal contract award is for $279,956.00 to provide clinical services and resources for the National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) from July 1, 2025 to December 31, 2025. The contract was awarded to The Johns Hopkins University, a private, non-profit research university in Baltimore, Maryland. The contract does not utilize any set-aside designations. The contract will support NIDA's mission to conduct research on the basic mechanisms of drug use and...
- This is a federal contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to The Johns Hopkins University. The contract has a ceiling value of $109,658.00 and is a definitive, cost-no-fee contract with a period of performance ending on June 30, 2017. The contract does not have a set-aside designation. The Johns Hopkins University, a private research university located in Baltimore, Maryland, is the prime contractor for...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to The Johns Hopkins University on August 30, 2017 for $100,000.00. The contract has an ultimate completion date of October 31, 2017 and is not set aside. The Johns Hopkins University is a private, non-profit research university that has extensive experience providing clinical trial and data coordination, statistical analysis, IT and software development, research and lab...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to The Johns Hopkins University. The contract has a ceiling value of $107,615.73 and a completion date of May 10, 2018. The Johns Hopkins University, a private research university located in Baltimore, Maryland, is the prime contractor for this award. This contract does not have a set-aside designation. Based on the...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $103,007.40 firm fixed price purchase order contract to The Johns Hopkins University, a private non-profit university located in Baltimore, Maryland. The contract has no set-aside designation and was awarded on September 7, 2018 with a completion date of January 10, 2020. As a leading research institution, The Johns Hopkins University has a history of providing the U.S. government...
- This is a $598,725.92 cost-plus-fixed-fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Johns Hopkins Bayview Medical Center, Inc., a non-profit hospital located in Baltimore, Maryland. The contract is for clinical services and resources in support of NIDA's Intramural Research Program (IRP), with a period of performance from July 1, 2019 to June 30, 2020. The contract was not set aside for any specific business category. Johns Hopkins Bayview Medical...
- The federal contract HHSN271201400042C, awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Johns Hopkins Bayview Medical Center, Inc. (Johns Hopkins Bayview) is for the provision of CLINICAL SUPPORT SERVICES AND RESOURCES. This is a Cost Plus Fixed Fee definitive contract with a potential value of $5,027,325.87 and a period of performance from July 29, 2014 to June 30, 2019. The contract was not set aside for any...
- The National Institutes of Health's National Institute on Drug Abuse awarded a $32,720 purchase order to The Johns Hopkins University for gene sequencing and profiling of sample tissue. This firm fixed price contract supports the NIH/NIDA's biomedical research efforts through Johns Hopkins' delivery of genomic analysis services. No subcontractors or set aside designations were identified. The one year period of performance begins in July 2023, with work conducted at Johns Hopkins' Bethesda,...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIH NIDA) awarded a Time and Materials contract valued at $270,000.00 to The Johns Hopkins University, a private non-profit research university, to provide custom radiosynthesis of positron emission tomography (PET) ligands and access to a small animal PET scanner. This one-year contract supports the NIH NIDA Neuroimaging Research Branch's research into molecular processes in the living...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, awarded a $569,619 cost-no-fee purchase order to The Johns Hopkins University for clinical services and resources supporting NIDA's Intramural Research Program (IRP) Clinical Research Program. The contract, which commenced January 1, 2026 and extends through June 30, 2026 (with ultimate completion by December 31, 2026), was awarded without set-aside designation following a sole-source justification determination. The government determined through market research that Johns Hopkins Bayview Medical Center, operating under The Johns Hopkins University parent entity, possessed unique capabilities to deliver the specialized clinical services required for NIDA's ongoing research operations. Services will be performed at Johns Hopkins University School of Medicine in Baltimore, Maryland, with contract administration by the NIH/NIDA Contracts Management Branch. This contract represents a continuation of NIDA's clinical research support relationship with Johns Hopkins, one of the nation's premier research institutions with an extensive portfolio of federal research contracts and grants. Johns Hopkins' biomedical research capabilities, clinical infrastructure, and established track record in supporting intramural research programs across federal agencies positioned it as the sole identified source capable of meeting NIDA's specialized clinical service requirements. The cost-no-fee contract structure indicates that Johns Hopkins will deliver services at cost without profit margin, consistent with arrangements often used for academic medical center partnerships supporting federal research missions.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Clinical Services and Resources for the National Institute on Drug Abuse, Intramural Research Program (NIDA, IRP) | 75N95026R00002 | Department of Health and Human Services National Institutes of Health | Special Notice 1/1 | 11/18/25, 1:44 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $283.4k | 12/22/25 |